title: Intrabiliary rapamycin may slow progression of primary sclerosing cholangitis.
authors.forename: F
authors.initials: F
authors.lastname: Karaahmet
authors.forename: S
authors.initials: S
authors.lastname: Kılıncalp
authors.forename: A
authors.initials: A
authors.lastname: Altınbas
authors.forename: S
authors.initials: S
authors.lastname: Coban
authors.forename: O
authors.initials: O
authors.lastname: Yuksel
mesh_terms: D015209:Cholangitis, Sclerosing / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus